National Institute of Mental Health; Notice of Closed Meeting, 58504 [2022-20840]
Download as PDF
<![CDATA[
58504
Federal Register / Vol. 87, No. 186 / Tuesday, September 27, 2022 / Notices
FDA is
requesting nomination for voting
members on the Tobacco Products
Scientific Advisory Committee.
SUPPLEMENTARY INFORMATION:
I. General Description of the Committee
Duties
The Tobacco Products Scientific
Advisory Committee advises the
Commissioner of Food and Drugs (the
Commissioner) or designee in
discharging responsibilities related to
the regulation of tobacco products. The
Committee reviews and evaluates safety,
dependence, and health issues, among
others, relating to tobacco products and
provides appropriate advice,
information, and recommendations to
the Commissioner.
jspears on DSK121TN23PROD with NOTICES
II. Criteria for Voting Members
The Committee shall consist of 12
members, including the Chair. Members
and the Chair are selected by the
Commissioner or designee from among
individuals knowledgeable in the fields
of medicine, medical ethics, science, or
technology involving the manufacture,
evaluation, or use of tobacco products.
Almost all non-Federal members of this
Committee serve as Special Government
Employees. The Committee shall
include nine technically qualified
voting members, selected by the
Commissioner or designee. The nine
voting members shall be physicians,
dentists, scientists, or healthcare
professionals practicing in the areas of
oncology, pulmonology, cardiology,
toxicology, pharmacology, addiction,
epidemiology, behavioral health, or any
other relevant specialty. One member
shall be an officer or employee of a State
or local government or of the Federal
Government. The final voting member
shall be a representative of the general
public. Members will be invited to serve
for terms of up to 4 years.
III. Nomination Procedures
Any interested person may nominate
one or more qualified individuals for
membership on the advisory committee.
Self-nominations are also accepted.
Nominations must include a current,
complete re´sume´ or curriculum vitae for
each nominee, including current
business address and/or home address,
telephone number, and email address if
available and a signed copy of the
Acknowledgement and Consent form
available at the FDA Advisory
Nomination Portal (see ADDRESSES).
Nominations must also specify the
advisory committee for which the
nominee is recommended. Nominations
must also acknowledge that the
nominee is aware of the nomination
unless self-nominated. FDA will ask
VerDate Sep<11>2014
17:51 Sep 26, 2022
Jkt 256001
potential candidates to provide detailed
information concerning such matters
related to financial holdings,
employment, and research grants and/or
contracts to permit evaluation of
possible sources of conflicts of interest.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: September 21, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–20866 Filed 9–26–22; 8:45 am]
BILLING CODE 4164–01–P
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the intramural research review cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: September 21, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20840 Filed 9–26–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Institute of Mental
Health. The meeting will be closed to
the public as indicated below in
accordance with the provisions set forth
in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended for the
review, discussion, and evaluation of
individual intramural programs and
projects conducted by the National
Institute of Mental Health, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of Mental
Health.
Date: October 12–13, 2022.
Time: October 12, 2022, 12:15 p.m. to 5:00
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892.
Time: October 13, 2022, 11:00 a.m. to 4:30
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892.
Contact Person: Jennifer E. Mehren, Ph.D.,
Scientific Advisor, Division of Intramural
Research Programs, National Institute of
Mental Health, NIH, 35A Convent Drive,
Room GE 412, Bethesda, MD 20892–3747,
301–496–3501, mehrenj@mail.nih.gov.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: November 7–8, 2022.
Time: 11:00 a.m. to 3:10 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Cancer Institute, 9609
Medical Center Drive, Rockville, MD 20850
(Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W414, Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsc/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 87, Number 186 (Tuesday, September 27, 2022)]
[Notices]
[Page 58504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20840]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Institute of Mental Health. The meeting will be
closed to the public as indicated below in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Mental Health, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Mental Health.
Date: October 12-13, 2022.
Time: October 12, 2022, 12:15 p.m. to 5:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892.
Time: October 13, 2022, 11:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892.
Contact Person: Jennifer E. Mehren, Ph.D., Scientific Advisor,
Division of Intramural Research Programs, National Institute of
Mental Health, NIH, 35A Convent Drive, Room GE 412, Bethesda, MD
20892-3747, 301-496-3501, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the intramural research review cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.242,
Mental Health Research Grants; 93.281, Scientist Development Award,
Scientist Development Award for Clinicians, and Research Scientist
Award; 93.282, Mental Health National Research Service Awards for
Research Training, National Institutes of Health, HHS)
Dated: September 21, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20840 Filed 9-26-22; 8:45 am]
BILLING CODE 4140-01-P
